AURO-SILODOSIN

auro pharma inc🇨🇦 Health Canada

Approval Id: b0bf20549737c694
Drug Approval Canada Name: AURO-SILODOSIN
Product Name: AURO-SILODOSIN
Status: Marketed
Status Date: 2022-02-16
Original Market Date: 2022-02-16
Din: 02478501
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 12:16.04.12
Atc Original: G04CA04 SILODOSIN
Atc Name: g 04 ca 04
Aig Number: 0152869001
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

SILODOSIN

4 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b0bf20549737c694

Type

Standard